Logo image of ABO.DE

CLEARVISE AG (ABO.DE) Stock Fundamental Analysis

FRA:ABO - Deutsche Boerse Ag - DE000A1EWXA4 - Common Stock - Currency: EUR

1.7  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ABO. ABO was compared to 22 industry peers in the Independent Power and Renewable Electricity Producers industry. ABO scores excellent on profitability, but there are concerns on its financial health. ABO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ABO had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: ABO reported negative net income in multiple years.
ABO had a positive operating cash flow in each of the past 5 years.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

1.2 Ratios

With a decent Return On Assets value of 2.23%, ABO is doing good in the industry, outperforming 63.64% of the companies in the same industry.
ABO has a better Return On Equity (5.28%) than 72.73% of its industry peers.
ABO has a better Return On Invested Capital (5.26%) than 90.91% of its industry peers.
ABO had an Average Return On Invested Capital over the past 3 years of 3.36%. This is below the industry average of 6.06%.
The 3 year average ROIC (3.36%) for ABO is below the current ROIC(5.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.23%
ROE 5.28%
ROIC 5.26%
ROA(3y)1.73%
ROA(5y)1.25%
ROE(3y)4.2%
ROE(5y)3.42%
ROIC(3y)3.36%
ROIC(5y)3.36%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

ABO has a Profit Margin of 11.75%. This is in the better half of the industry: ABO outperforms 63.64% of its industry peers.
In the last couple of years the Profit Margin of ABO has grown nicely.
ABO's Operating Margin of 30.43% is fine compared to the rest of the industry. ABO outperforms 63.64% of its industry peers.
In the last couple of years the Operating Margin of ABO has grown nicely.
ABO has a Gross Margin of 95.24%. This is amongst the best in the industry. ABO outperforms 86.36% of its industry peers.
ABO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 30.43%
PM (TTM) 11.75%
GM 95.24%
OM growth 3Y-2.84%
OM growth 5Y2.37%
PM growth 3Y32.86%
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-0.98%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABO is still creating some value.
ABO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ABO has been increased compared to 5 years ago.
Compared to 1 year ago, ABO has an improved debt to assets ratio.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

ABO has an Altman-Z score of 0.90. This is a bad value and indicates that ABO is not financially healthy and even has some risk of bankruptcy.
ABO has a Altman-Z score (0.90) which is in line with its industry peers.
A Debt/Equity ratio of 1.00 is on the high side and indicates that ABO has dependencies on debt financing.
ABO has a Debt to Equity ratio (1.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 0.9
ROIC/WACC1.23
WACC4.28%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.3 Liquidity

ABO has a Current Ratio of 1.17. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
ABO's Current ratio of 1.17 is in line compared to the rest of the industry. ABO outperforms 50.00% of its industry peers.
A Quick Ratio of 1.17 indicates that ABO should not have too much problems paying its short term obligations.
ABO has a Quick ratio of 1.17. This is comparable to the rest of the industry: ABO outperforms 54.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

3

3. Growth

3.1 Past

ABO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.01%.
ABO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.96% yearly.
Looking at the last year, ABO shows a very negative growth in Revenue. The Revenue has decreased by -31.18% in the last year.
Measured over the past years, ABO shows a small growth in Revenue. The Revenue has been growing by 7.20% on average per year.
EPS 1Y (TTM)-73.01%
EPS 3Y21.96%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-31.18%
Revenue growth 3Y7.15%
Revenue growth 5Y7.2%
Sales Q2Q%N/A

3.2 Future

ABO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -32.16% yearly.
ABO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.58% yearly.
EPS Next Y-138.86%
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%
EPS Next 5YN/A
Revenue Next Year-17.04%
Revenue Next 2Y-2.32%
Revenue Next 3Y3.58%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1 0.15

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.45, ABO is valued correctly.
77.27% of the companies in the same industry are more expensive than ABO, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ABO to the average of the S&P500 Index (29.35), we can say ABO is valued slightly cheaper.
ABO is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 15.45
Fwd PE N/A
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABO is valued a bit cheaper than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.09
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

ABO has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as ABO's earnings are expected to decrease with -32.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%

0

5. Dividend

5.1 Amount

No dividends for ABO!.
Industry RankSector Rank
Dividend Yield N/A

CLEARVISE AG

FRA:ABO (3/7/2025, 7:00:00 PM)

1.7

0 (0%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)09-12 2024-09-12
Earnings (Next)04-28 2025-04-28/amc
Inst Owners5.76%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap128.11M
Analysts85
Price Target3.37 (98.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-13.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.31%
Valuation
Industry RankSector Rank
PE 15.45
Fwd PE N/A
P/S 1.77
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.8
EV/EBITDA 7.09
EPS(TTM)0.11
EY6.47%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.96
BVpS2.13
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.23%
ROE 5.28%
ROCE 6.47%
ROIC 5.26%
ROICexc 5.89%
ROICexgc 5.89%
OM 30.43%
PM (TTM) 11.75%
GM 95.24%
FCFM N/A
ROA(3y)1.73%
ROA(5y)1.25%
ROE(3y)4.2%
ROE(5y)3.42%
ROIC(3y)3.36%
ROIC(5y)3.36%
ROICexc(3y)4.06%
ROICexc(5y)3.9%
ROICexgc(3y)4.12%
ROICexgc(5y)3.99%
ROCE(3y)4.14%
ROCE(5y)4.13%
ROICexcg growth 3Y-12.43%
ROICexcg growth 5Y0.76%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y1.65%
OM growth 3Y-2.84%
OM growth 5Y2.37%
PM growth 3Y32.86%
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-0.98%
F-ScoreN/A
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.05
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 0.9
F-ScoreN/A
WACC4.28%
ROIC/WACC1.23
Cap/Depr(3y)80.88%
Cap/Depr(5y)48.91%
Cap/Sales(3y)30.59%
Cap/Sales(5y)18.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.01%
EPS 3Y21.96%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-138.86%
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-31.18%
Revenue growth 3Y7.15%
Revenue growth 5Y7.2%
Sales Q2Q%N/A
Revenue Next Year-17.04%
Revenue Next 2Y-2.32%
Revenue Next 3Y3.58%
Revenue Next 5YN/A
EBIT growth 1Y-65.91%
EBIT growth 3Y4.1%
EBIT growth 5Y9.75%
EBIT Next Year69.67%
EBIT Next 3Y31.75%
EBIT Next 5YN/A
FCF growth 1Y-26.38%
FCF growth 3Y-14.34%
FCF growth 5Y6.36%
OCF growth 1Y-66.66%
OCF growth 3Y-13.84%
OCF growth 5Y-5.59%